Tresiba® (insulin degludec) is a once-daily, ultra-long-acting basal insulin analog indicated for the treatment of diabetes mellitus in adults, adolescents, and children aged 1 year and above. It provides a steady insulin release, reducing blood sugar levels and minimizing the risk of hypoglycemia. The FlexTouch® pen offers ease of use with its pre-filled, ready-to-inject design. . Please Note that product description, color, ingredients, package and other information maybe different from the original pack kindly check the product for more accurate details.
